| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 12 Mar 2025 | LKP Securities Limited | Buy | ₹2,207.8 | ₹2,900 | 30.6% | moneycontrol | View |
| 25 Jul 2024 | ICICI Securities | Hold | ₹2,023.1 | ₹1,940 | -30.7% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| POLY MEDICURE LTD. | 4,778.26 | 917.98 | 4,438.82 | 9.06 | 19,855 | 55.5 |
| NEULAND LABORATORIES LTD. | 5160.72 | 964.59 | 5142.73 | 75.18 | 17918 | 136.0 |
| ALEMBIC PHARMACEUTICALS LTD. | 19,170.60 | 1,837.10 | 19,101.50 | 9.40 | 17885 | 30.2 |
Poly Medicure Ltd, with Security Code 531768, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 319.9 | 320.9 | 360.9 | 367.4 | 402.5 | 410.9 | 421.0 | 384.0 |
| Expenses | 237.3 | 236.5 | 263.5 | 266.2 | 289.5 | 295.3 | 304.9 | 282.4 |
| Operating Profit | 82.6 | 84.4 | 97.4 | 101.2 | 112.9 | 115.6 | 116.1 | 101.6 |
| OPM % | 25.82% | 26.3% | 26.99% | 27.54% | 28.06% | 28.13% | 27.57% | 26.46% |
| Other Income | 12.8 | 16.6 | 15.7 | 16.8 | 27.2 | 21.7 | 23.9 | 41.1 |
| Interest | 2.1 | 3.4 | 2.9 | 3.0 | 3.1 | 3.1 | 2.2 | 2.8 |
| Depreciation | 15.3 | 15.5 | 16.2 | 19.0 | 20.1 | 20.8 | 21.3 | 22.8 |
| Profit before tax | 78.0 | 82.1 | 94.0 | 96.1 | 116.9 | 113.4 | 116.5 | 117.1 |
| Tax % | -24.1% | -25.1% | -24.9% | -24.7% | -25.4% | -24.9% | -25.6% | 24.9% |
| Net Profit | 59.2 | 61.5 | 70.5 | 72.3 | 87.2 | 85.2 | 86.7 | 87.9 |
| EPS in Rs | 6.17 | 6.4 | 7.35 | 7.53 | 8.98 | 8.48 | 0 | 8.67 |
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 339.6 | 378.1 | 384.8 | 420.0 | 424.2 | 440.8 | 443.9 | 443.9 |
| Expenses | 249.4 | 281.5 | 280.9 | 304.7 | 309.7 | 321.3 | 329.2 | 329.2 |
| Operating Profit | 90.2 | 96.6 | 103.9 | 115.3 | 114.5 | 119.5 | 114.7 | 114.7 |
| OPM % | 26.57% | 25.55% | 27.01% | 27.46% | 27% | 27.11% | 25.84% | 25.84% |
| Other Income | 16.6 | 15.0 | 16.9 | 26.1 | 21.8 | 24.3 | 33.9 | 33.9 |
| Interest | 3.5 | 3.1 | 3.2 | 3.3 | 3.3 | 2.2 | 3.0 | 3.0 |
| Depreciation | 16.2 | 16.2 | 19.7 | 20.9 | 21.5 | 21.0 | 24.9 | 24.9 |
| Profit before tax | 87.1 | 92.2 | 98.0 | 117.2 | 111.5 | 120.6 | 120.7 | 120.7 |
| Tax % | -26.2% | -26.1% | -24.9% | -26% | -25.1% | -25.7% | 24.8% | -24.8% |
| Net Profit | 65.0 | 68.4 | 74.0 | 87.5 | 85.2 | 91.8 | 91.8 | 91.8 |
| EPS in Rs | 6.77 | 7.12 | 7.71 | 9.01 | 8.48 | 0 | 9.06 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 20% |
| 3 Years: | 22% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 29% |
| 3 Years: | 36% |
| TTM: | 40% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 57% |
| 3 Years: | 52% |
| 1 Year: | 35% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 19% |
| 3 Years: | 22% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 29% |
| 3 Years: | 34% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 57% |
| 3 Years: | 52% |
| 1 Year: | 35% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|